Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial
de Yebenes, Justo Garcia, Dr, Landwehrmeyer, Bernhard, MD, Squitieri, Ferdinando, MD, Reilmann, Ralf, MD, Rosser, Anne, MD, Barker, Roger A, MD, Saft, Carsten, MD, Magnet, Markus K, MD, Sword, Alastair, MSc, Rembratt, Åsa, PhD, Tedroff, Joakim, MD
Published in Lancet neurology (01.12.2011)
Published in Lancet neurology (01.12.2011)
Get full text
Journal Article